drugset

drugset / Trial / NCT07601087

A Clinical Study of HRS-7156 in Healthy Participants

NCT07601087 ↗

Phase 1 Recruiting 66 enrolled Shandong Suncadia Medicine Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this Phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-7156 in healthy participants.

Timeline

Start: 2026-06-12
Primary completion: 2026-07
Completion: 2026-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-7156	Unknown	—	Oral

Indications